0000014272-20-000162.txt : 20200505 0000014272-20-000162.hdr.sgml : 20200505 20200505164924 ACCESSION NUMBER: 0000014272-20-000162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200501 FILED AS OF DATE: 20200505 DATE AS OF CHANGE: 20200505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AHMED NADIM CENTRAL INDEX KEY: 0001731193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 20849671 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 430 E. 29TH STREET STREET 2: 14 FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 wf-form4_158871174702049.xml FORM 4 X0306 4 2020-05-01 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001731193 AHMED NADIM 430 E. 29TH STREET 14TH FLOOR NEW YORK NY 10016 0 1 0 0 EVP and President, Hematology Common Stock, $0.10 par value 2020-05-01 4 M 0 2908 0 A 27463 D Common Stock, $0.10 par value 2020-05-01 4 F 0 1433 60.26 D 26030 D Common Stock, $0.10 par value 1966 I 401(k) Restricted Stock Units 2020-05-01 4 M 0 2908 0 A 2020-05-01 Common Stock, $0.10 par value 2908.0 0 D The restricted stock unit vests in three equal installments beginning on May 1, 2018. Shares withheld for payment of taxes upon vesting of awards. Based on recent plan statement. Each restricted stock unit converts into one share of common stock upon vesting. /s/ Lisa A. Atkins, attorney-in-fact for Nadim Ahmed 2020-05-05